BRISBANE, Calif.--(BUSINESS WIRE)--Tercica, Inc. (Nasdaq:TRCA) today announced that Richard A. King has been appointed as Chief Operating Officer. Mr. King, 42, previously served as Executive Vice President, Commercial Operations of Kos Pharmaceuticals, Inc. from 2002 to 2006, where he was responsible for sales, marketing, managed care, sales operations and customer service functions. Under his commercial leadership, Kos realized revenue growth from $90 million in 2001 to approximately $750 million in 2005. Kos attained profitability in 2003, and by 2006, when the company was acquired by Abbott Laboratories, Mr. King had approximately 1,000 professional personnel reporting to him.
